Servicio de Cardiología, Hospital Ramón y Cajal, IRYCIS, Madrid, España.
Medicina Familiar y Comunitaria, Hospital Ramón y Cajal, IRYCIS, Madrid, España.
Arch Bronconeumol. 2017 Sep;53(9):495-500. doi: 10.1016/j.arbres.2017.02.011. Epub 2017 Mar 31.
Clinical presentation and short-term prognosis of patients with travel-associated acute pulmonary embolism (PE) (i.e., economy class syndrome [ECS]) is not well understood.
In this retrospective cohort study of patients with acute PE identified from a single center registry, we assessed the clinical presentation and the association between ECS and the outcomes of all-cause mortality, PE-related mortality, nonfatal venous thromboembolism and nonfatal major bleeding rates through 30days after initiation of PE treatment.
Of the 2,333 patients with acute symptomatic PE, 124 (5.3%; 95% confidence interval, 4.4-6.3%) had ECS. Patients with ECS were younger and had fewer comorbid diseases (recent bleeding, chronic obstructive pulmonary disease, congestive heart failure), but they presented with more signs of clinical severity (syncope [48% vs. 14%; P<.001], tachycardia [37% vs. 21%; P<.001], right ventricular dysfunction [31% vs. 19%; P<.01] and myocardial injury [57% vs. 28%; P<.001]) compared to those without ECS. Regression analyses showed a significantly lower risk of all-cause mortality for patients with ECS compared to patients without ECS (1.6% vs. 9.6%; P<.01). We did not detect a difference in PE-related mortality at 30days between those with and those without ECS (0.8% vs. 3.1%; P=.18).
PE patients with ECS are younger and have fewer comorbid diseases compared to those without ECS. Though they present with more signs of clinical severity, their short-term prognosis is excellent.
旅行相关的急性肺栓塞(PE)(即经济舱综合征[ECS])患者的临床表现和短期预后尚不清楚。
在这项对单中心登记处确定的急性 PE 患者进行的回顾性队列研究中,我们评估了 ECS 与所有原因死亡率、PE 相关死亡率、非致命性静脉血栓栓塞和非致命性大出血发生率之间的关系,并通过 PE 治疗开始后 30 天进行评估。
在 2333 例有症状的急性 PE 患者中,有 124 例(5.3%;95%置信区间,4.4-6.3%)患有 ECS。ECS 患者较年轻,合并症较少(近期出血、慢性阻塞性肺疾病、充血性心力衰竭),但临床表现更为严重(晕厥[48%比 14%;P<.001]、心动过速[37%比 21%;P<.001]、右心室功能障碍[31%比 19%;P<.01]和心肌损伤[57%比 28%;P<.001])。回归分析显示,与无 ECS 患者相比,ECS 患者的全因死亡率显著降低(1.6%比 9.6%;P<.01)。我们未发现 30 天内有 ECS 和无 ECS 的患者之间 PE 相关死亡率存在差异(0.8%比 3.1%;P=.18)。
与无 ECS 的患者相比,ECS 的 PE 患者更年轻,合并症较少。尽管他们表现出更严重的临床症状,但他们的短期预后良好。